Velindre Hospital

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Childhood cancers3 trials
• Prostate cancer3 trials
• Lung cancer2 trials
• Colorectal cancer1 trial
• Gastric and oesophageal cancer1 trial
• Sarcoma1 trial

Phase

• Phase 35 trials
• Phase 1/21 trial

Status

• Active, not recruiting3 trials
• Recruiting3 trials
• Completed1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• pharmaand GmbH1 trial
• Royal Marsden NHS Foundation Trust1 trial
• University College, London1 trial
• University of Birmingham1 trial
• and 1 more

Running trials

• Recruiting

  A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

  NCT07230691· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure

  NCT04988295· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

  NCT04625907· Phase 1/2· University of Birmingham· Source

  Contact: D W Owen Tilsley

• Active, not recruiting

  Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

  NCT02804815· Phase 3· University College, London· Source

• Recruiting

  Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

  NCT02582697· Phase 3· University of Sydney· Source

  Contact: Sonya Osborne

• Active, not recruiting

  Prostate Advances in Comparative Evidence

  NCT01584258· Phase 3· Royal Marsden NHS Foundation Trust· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers2 recruiting
• Lung cancer1 recruiting
• Sarcoma1 recruiting

Closed trials

• Completed

  A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

  NCT02975934· Phase 3· pharmaand GmbH· Source